CSK and breast cancer: Knockdown of SHP2 increased the complex formations of cSrc-Csk, cSrc-p140Cap and cSrc-p-caveolin-1, subsequently inducing phosphorylation of cSrc at tyrosine 527 and inactivation of cSrc, and eventually abolished the P4-promoted breast cancer proliferation and migration.